FDA — authorised 28 September 2017
- Application: NDA208716
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: VERZENIO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Verzenio in United States
FDA authorised Verzenio on 28 September 2017
Marketing authorisations
FDA
- Application: ANDA220238
- Marketing authorisation holder: QILU PHARMACEUTICAL CO., LTD.
- Local brand name: ABEMACICLIB
- Indication: TABLET
- Status: approved
Verzenio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Verzenio approved in United States?
Yes. FDA authorised it on 28 September 2017; FDA has authorised it.
Who is the marketing authorisation holder for Verzenio in United States?
ELI LILLY AND CO holds the US marketing authorisation.